An exploratory study to identify risk factors for the development of capecitabine‐induced Palmar Plantar Erythrodysesthesia (PPE)

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2648|71|8|1825-1832

ISSN： 0309-2402

Source： JOURNAL OF ADVANCED NURSING, Vol.71, Iss.8, 2015-08, pp. : 1825-1832

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Palmar-Plantar Erythrodysesthesia Associated with Chemotherapy and Its Treatment

By  

Case Reports in Oncology, Vol. 4, Iss. 1, 2011-04 ,pp. : 229-235

Karger

Access to resources Recommend Favorite

Fatal Palmar-Plantar Erythrodysesthesia after Clofarabine and Cytarabine Chemotherapy

By  

Acta Haematologica, Vol. 128, Iss. 3, 2012-08 ,pp. : 151-153

Karger

Access to resources Recommend Favorite

Hand-Foot Syndrome (Hand-Foot Skin Reaction, Palmar-Plantar Erythrodysesthesia): Focus on Sorafenib and Sunitinib

By  

Oncology, Vol. 77, Iss. 5, 2009-11 ,pp. : 257-271

Karger

Access to resources Recommend Favorite

Pyridoxine as Prophylactic Therapy for Palmar-Plantar Erythrodysesthesia Associated with Administration of Pegylated Liposomal Doxorubicin (Caelyx): A Single-Center Experience

By  

Oncology, Vol. 73, Iss. 3-4, 2008-04 ,pp. : 277-278

Karger

Access to resources Recommend Favorite

Capecitabine-Induced Coronary Vasospasm

By  

Case Reports in Oncology, Vol. 9, Iss. 3, 2016-10 ,pp. : 629-632

Karger

Access to resources Recommend Favorite